Note: Ingredients listed on restricted chemical lists
EC/CAS
234-394-2/11138-66-2
Name of the chemical
xanthan gum
Concentration
>96.0
General Information
Revision date
2020-09-11
Product name
ELTROMBOPAG POWDER FOR ORAL SUSPENSION SACHET
Product Synonyms
ELTROMBOPAG 20MG SACHET * ELTROMBOPAG 25MG SACHET *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H411
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.
Health hazards
Serious eye damage/eye irritation Category 2 H319 - Causes serious eye irritation.
Environmental hazards
Hazardous to the aquatic environment, Category 2 H411 - Toxic to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Assume that this product is capable of sustaining combustion. Caution - Pharmaceutical agent. Exposure to powder or dusts may be irritating to eyes, nose and throat. Causes serious eye irritation. See section 11 of the SDS for additional information on health hazards. Dangerous for the environment if discharged into watercourses.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
ELTROMBOPAG OLAMINE, SUCRALOSE, XANTHAN GUM
Signal word
Warning
Hazard statements
H319 Causes serious eye irritation. H411 Toxic to aquatic life with long lasting effects.
Prevention
P264 Wash thoroughly after handling. P273 Avoid release to the environment. P280 Wear eye protection/face protection.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/attention. P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
3.96 % of the mixture consists of component(s) of unknown acute dermal toxicity. 3.96 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 2.56 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment.
2.3 Other hazards
Assume that this material is capable of sustaining combustion. Assume that this material is capable of being ignited by an electrostatic discharge. Assume that this material is capable of producing a dust explosion if ignited as a dust cloud. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
